HUE059233T2 - Vegyület epizootius nyúl-enteropátia kezelésében és/vagy megelõzésében való alkalmazásra - Google Patents

Vegyület epizootius nyúl-enteropátia kezelésében és/vagy megelõzésében való alkalmazásra

Info

Publication number
HUE059233T2
HUE059233T2 HUE18179396A HUE18179396A HUE059233T2 HU E059233 T2 HUE059233 T2 HU E059233T2 HU E18179396 A HUE18179396 A HU E18179396A HU E18179396 A HUE18179396 A HU E18179396A HU E059233 T2 HUE059233 T2 HU E059233T2
Authority
HU
Hungary
Prior art keywords
epizootic
enteropathy
rabbit
prevention
compound
Prior art date
Application number
HUE18179396A
Other languages
English (en)
Inventor
Spas Petkov
Veerle Hautekiet
Gaver Davy Philip Van
Original Assignee
Huvepharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huvepharma filed Critical Huvepharma
Publication of HUE059233T2 publication Critical patent/HUE059233T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE18179396A 2018-06-22 2018-06-22 Vegyület epizootius nyúl-enteropátia kezelésében és/vagy megelõzésében való alkalmazásra HUE059233T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18179396.9A EP3586834B1 (en) 2018-06-22 2018-06-22 Compound for use in the treatment and/or prevention of epizootic rabbit enteropathy

Publications (1)

Publication Number Publication Date
HUE059233T2 true HUE059233T2 (hu) 2022-10-28

Family

ID=62750891

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18179396A HUE059233T2 (hu) 2018-06-22 2018-06-22 Vegyület epizootius nyúl-enteropátia kezelésében és/vagy megelõzésében való alkalmazásra

Country Status (3)

Country Link
EP (1) EP3586834B1 (hu)
ES (1) ES2914792T3 (hu)
HU (1) HUE059233T2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4393494A1 (en) * 2022-12-28 2024-07-03 Huvepharma Compound for use in the treatment and/or prevention of a clostridium difficile infection in a pig

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1068639A (en) 1964-09-21 1967-05-10 Hoechst Ag A purified form of the antibiotic moenomycin and a process for its manufacture
DE1247549B (de) 1965-02-25 1967-08-17 Hoechst Ag Verfahren zur fermentativen Gewinnung des Antibiotikums Moenomycin

Also Published As

Publication number Publication date
EP3586834A1 (en) 2020-01-01
EP3586834B1 (en) 2022-03-02
ES2914792T3 (es) 2022-06-16

Similar Documents

Publication Publication Date Title
IL282487B1 (en) Tyk2 inhibitors and their use
IL281999A (en) YAP/TAZ-TEAD interaction inhibitors and their use in cancer therapy
IL283409A (en) tyk2 inhibitors and uses thereof
IL282090B2 (en) TYK2 inhibitors and their uses
IL277794A (en) ATF6 inhibitors and uses thereof
HUE069231T2 (hu) Aprocitentán magas vérnyomás és kapcsolódó betegségek kezelésében történõ alkalmazásra, kombinációban valzartánnal
IL282350A (en) Bernani-RGMC inhibitors and their use
IL279347A (en) Gremlin-1 antagonist for cancer prevention and treatment
GB201820450D0 (en) Compound and its use for the treatment of alpha1-antitryspin deficiency
IL270976A (en) IL-8 inhibitors for use in the treatment and/or prevention of secondary bacterial infection
ZA202307970B (en) Compounds for use in the treatment and prevention of covid- 19
GB202204420D0 (en) Crypto-erasure via internal and/or external action
IL275875A (en) Treatment and prevention of sleep disorders
PT3661490T (pt) Composição para utilização na prevenção e/ou tratamento de mucositite oral gastrointestinal induzida por tratamento oncológico
PL3541185T3 (pl) Zastosowanie 2-hydroksybenzyloaminy w leczeniu i zapobieganiu nadciśnieniu płucnemu
PL3902548T3 (pl) Inhibitor egfr z powodującą oporność na leczenie mutacją l718 i/lub l792 do stosowania w leczeniu nowotworu
ZA202006886B (en) R-fadrozole for use in the treatment of aldostonerism
HUE059233T2 (hu) Vegyület epizootius nyúl-enteropátia kezelésében és/vagy megelõzésében való alkalmazásra
GB201918404D0 (en) Compounds and their use for the treatment of aplha1-antitrypsin deficiency
PL3829553T3 (pl) Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego
HK40027245A (en) Il-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections
GB201918539D0 (en) Compounds for use in treatment and prophylaxis
GB201820455D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820452D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency
GB201820451D0 (en) Compounds and their use for the treatment of alpha1-antitryspin deficiency